RING1B is highly expressed in a number of human malignancies including prostate cancer, pancreatic ductal adenocarcinoma, ovarian cancer and urothelial bladder carcinoma [92,105,106,107]. This evidence concerns the gene RNF2 and bladder transitional cell carcinoma.